Thus, treatment with 5-aza-dC alone was not able to reinstate gene expression in all the lung cancer cell lines or demethylate the promoter region of Cadm1 and these observations led us to suspect for additional layers of epigenetic silencing in place. The gene discussed is CADM1; the disease is lung carcinoma.